trial · primary record
Gemcitabine
Mycosis Fungoides
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2027-07 |
| Primary endpoint | Overall Response Rate |
| Registry ID | NCT04960618 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:44.722Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04960618
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.